New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 21, 2014
09:21 EDTAZN, TEVA, MNTA, CBEY, ATHN, ACTG, AMD, ABX, NEM, NUS, RNA, SRPT, PFE, MUOn The Fly: Pre-Market Movers
HIGHER: Sarepta (SRPT), up 54% after announcing plans to to submit NDA for Eteplirsen by year end 2014. Shares of Prosnesa (RNA), another drugmaker working on a competing DMD drug, are up more than 12%... AstraZeneca (AZN), up 6% after the Sunday Times says that Pfizer (PFE) is considering a takeover bid for the company. Pfizer is up 1.2% following the report... Newmont Mining (NEM), up 8% after WSJ says the company and Barrick Gold (ABX) could resume merger talks as soon as today... Cbeyond (CBEY), up 39% after agreeing to be acquired for about $323M by Birch Communications... Momenta Pharma (MNTA), up 10.5% after the Supreme Court rejected Teva's (TEVA) bid to delay generic Copaxone... Nu Skin (NUS), up 5% after saying its China division will resume corporate-hosted business meetings... Micron (MU), up 4% after price target raised at Drexel Hamilton... DOWN AFTER EARNINGS: Acacia Research (ACTG), down 6%... athenahealth (ATHN), down 5.6%.
News For AZN;PFE;SRPT;RNA;NUS;NEM;ABX;AMD;ACTG;ATHN;CBEY;MNTA;TEVA;MU From The Last 14 Days
Check below for free stories on AZN;PFE;SRPT;RNA;NUS;NEM;ABX;AMD;ACTG;ATHN;CBEY;MNTA;TEVA;MU the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
July 21, 2014
10:42 EDTATHNOptions with decreasing implied volatility
Subscribe for More Information
08:11 EDTTEVAArena Pharma' subsidiary enters into agreement for Belviq with Teva subsidiary
Subscribe for More Information
08:01 EDTTEVATeva completes acquisition of Labrys
Subscribe for More Information
07:49 EDTATHNathenahealth shares should be bought on weakness, says Stifel
Stifel believes that athenahealth reported solid Q2 results, and the firm thinks the company has a number of upcoming positive catalysts. The firm believes that the company is in the midst of a positive turning point and keeps a $155 price target and Buy rating.
July 18, 2014
16:20 EDTAMDOn The Fly: Closing Wrap
Subscribe for More Information
15:18 EDTABX, NEMGoldcorp showed interest in Newmont Ghana mines, Bloomberg says
Goldcorp (GG) showed interest in potentially buying gold mines in Africa from Newmont Mining (NEM) while the latter was in merger talks with Barrick Gold (ABX) earlier this year, said Bloomberg, citing people familiar with the situation. Reference Link
14:53 EDTABX, NEMGoldcorp showed interest in Newmont Mining assets in Africa, Bloomberg says
Subscribe for More Information
12:42 EDTAMDOn The Fly: Midday Wrap
Stocks on Wall Street began the session in positive territory and have remained there throughout the morning. The averages moved in a narrow range for most of the opening hour of the session but spurted to higher levels during the second hour. Investors appear to be using yesterday’s sell-off as a buying opportunity, despite the ongoing events in Russia and Israel that largely contributed to yesterday’s action. ECONOMIC EVENTS: The first release of the University of Michigan consumer sentiment index for July fell to 81.3 after ending June with an 82.5 reading. The leading economic indicator index rose 0.3% to 102.2, which was a bit below the forecast for an increase of 0.5%. COMPANY NEWS: Class A shares of Google (GOOGL) advanced over 3% after the search giant reported quarterly revenue that beat expectations last night. Following its report, at least three Wall Street research firms raised their price targets on the stock, while noted tech analyst Collin Gillis of BGC Financial upgraded the stock to Buy from Hold... Dow component General Electric (GE) reported second quarter EPS of 39c, matching the consensus forecast, and revenue that just missed the consensus view of analysts. The company also reported that it is targeting the initial public offering of IPO of Synchrony Financial (SYF), its North American Retail Finance business, for July. In the IPO, Synchrony is offering 125M shares of its common stock, which will be listed on the New York Stock Exchange under the symbol “SYF,” and anticipates that the IPO price of the shares will be between $23.00 and $26.00 per share... Another Dow member, IBM (IBM), fell 0.4% after reporting adjusted Q2 earnings per share and revenue that beat expectations. Afterward, Cantor said it thinks the worst is over for the company and reiterated its Buy rating on the shares, though Societe Generale downgraded IBM to Sell from Hold and Credit Suisse said IBM continues to be driven by less revenue growth and kept its Underperform rating and $160 price target on Big Blue's stock. MAJOR MOVERS: Among the notable gainers was Skyworks (SWKS), which gained 14% after reporting third quarter results and fourth quarter guidance above analyst estimates and seeing no less than five analyst firms raise their price targets on its stock. Also higher was Gentiva Health (GTIV), which rose 14% after it announced that its board unanimously determined to reject the partial tender offer from Kindred Healthcare (KND) to acquire 14.9% of the outstanding shares of Gentiva for a price of $16.00 per share in cash and disclosed that it has received a $17.25 per share, all-cash takeover proposal from a "recognized owner, operator and investor in the sector." After the announcement, shares of Kindred fell 2%. Also lower following their earnings reports were RealPage (RP), which fell over 21%, and Advanced Micro Devices (AMD), which dropped nearly 18%. INDEXES: Near midday, the Dow was up 107.05, or 0.63%, to 17,083.86, the Nasdaq was up 57.98, or 1.33%, to 4,421.43, and the S&P 500 was up 17.04, or 0.87%, to 1,975.16.
11:42 EDTAMD, MUAMD plummets after profit miss, analyst downgrades
Subscribe for More Information
11:07 EDTATHNathenahealth defended, sell-off overdone, says Leerink
Subscribe for More Information
10:48 EDTAMDHigh option volume stocks
Subscribe for More Information
10:03 EDTNUS, AMDOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:29 EDTAMDAMD fundamentals still intact, says Wedbush
After AMD reported lower than expected Q2 pro forma EPS, Wedbush says that Q2 was the fourth consecutive quarter for which the company demonstrated profitability, tight OpEx controls, and continued product execution. It thinks these trends are significantly positive and keeps an Outperform rating on the shares.
09:24 EDTAMD, NUSOn The Fly: Pre-market Movers
Subscribe for More Information
09:11 EDTAMDAMD downgraded to Market Perform from Outperform at FBR Capital
FBR Capital downgraded AMD to Market Perform citing a lack of earnings visibility following the company's weaker than expected Q3 outlook. The firm lowered its price target for shares to $4.50 from $6. Note shares were also downgraded this morning at BofA/Merrill.
08:14 EDTAMDAMD downgraded at BofA/Merrill
Subscribe for More Information
06:52 EDTAMDAMD downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
06:52 EDTNUSNu Skin downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
06:12 EDTAMDAMD downgraded to Market Perform from Outperform at FBR Capital
06:02 EDTMUDRAMeXchange: Global DRAM module sales grew 32% in 2013, DigiTimes says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use